Accord And Aspire Beat Bimatoprost Patent In The UK

 
• By Aidan Fry
  
Eye drops
A patent barrier to generic bimatoprost 0.01% eye drops has been knocked down by the UK Patents Court • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Generics Bulletin